Fluorescence imaging of tumors with smart ph-activatable targeted probes

Methods in Molecular Biology

Volumn 574, Issue , 2009, Pages 47-62

  Asanuma, Daisuke ^a   Kobayashi, Hisataka ^b   Nagano, Tetsuo ^a   Urano, Yasuteru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

fluorescence; molecular probes; Optical tumor imaging; pH; receptor mediated endocytosis

Indexed keywords

EID: 84934436371     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-321-3_5     Document Type: Article

References (14)

1. Hengerer, A., Wunder, A., Wagenaar, D. J., Vija, A. H., Shah, M., and Grimm, J. (2005) From genomics to clinical molecular imaging. Proceedings of the IEEE 93, 819-828.
2. Krohn, K. A., O'Sullivan, F., Crowley, J., Eary, J. F., Linden, H. M., Link, J. M., Mankoff, D. A., Muzi, M., Rajendran, J. G., Spence, A. M., and Swanson, K. R. (2007) Challenges in clinical studies with multiple imaging probes. Nucl Med Biol 34, 879-885.
3. Becker, A., Hessenius, C., Licha, K., Ebert, B., Sukowski, U., Semmler, W., Wiedenmann, B., and Grotzinger, C. (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19, 327-331.
4. Moon, W. K., Lin, Y., O'Loughlin, T., Tang, Y., Kim, D. -E., Weissleder, R., and Tung, C. -H. (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14, 539-545.
5. Weissleder, R., Tung, C. -H., Mahmood, U., and Bogdanov, A. (1999) In vivo imaging of tumors with protease-activated nearinfrared fluorescent probes. Nat Biotechnol 17, 375-378.
6. Bremer, C., Tung, C. -H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7, 743-748.
7. Hama, Y., Urano, Y., Koyama, Y., Kamiya, M., Bernardo, M., Paik, R. S., Shin, I. S., Paik, C. H., Choyke, P. L., and Kobayashi, H. (2007) A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res 67, 2791-2799.
8. Kamiya, M., Kobayashi, H., Hama, Y., Koyama, Y., Bernardo, M., Nagano, T., Choyke, P. L., and Urano, Y. (2007) An enzymatically activated fluorescence probe for targeted tumor imaging. J Am Chem Soc 129, 3918-3929.
9. Hama, Y., Urano, Y., Koyama, Y., Choyke, P. L., and Kobayashi, H. (2006) Targeted optical imaging of cancer cells using lectinbinding BODIPY conjugated avidin. Biochem Biophys Res Commun 348, 807-813.
10. Austin, C. D., De Maziere, A. M., Pisacane, P. I., van Dijk, S. M., Eigenbrot, C., Sliwkowski, M. X., Klumperman, J., and Scheller, R. H. (2004) Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol Biol Cell 15, 5268-5282.
11. Hongyan Li, Z. M. Q. (2002) Transferrin/ transferrin receptor-mediated drug delivery. Med Res Rev 22, 225-250.
12. Konan, Y. N., Gurny, R., and Allemann, E. (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol 66, 89-106.
13. Atobe, K., Ishida, T., Ishida, E., Hashimoto, K., Kobayashi, H., Yasuda, J., Aoki, T., Obata, K. -I., Kikuchi, H., Akita, H., Asai, T., Harashima, H., Oku, N., and Kiwada, H. (2007) In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP). Biol Pharm Bull 30, 972-978.
14. Urano, Y., Asanuma, D., Hama, Y., Koyama, Y., Barrett, T., Kamiya, M., Nagano, T., Watanabe, T., Hasegawa, A., Choyke, P. L., and Kobayashi, H. (2009). Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 15(1): 104-109.